SCHEMBL6539702

SCHEMBL6539702

CCOC(=O)c1nc(-c2ccc(OC)cc2)c(-c2ccc(OCc3ccccc3)cc2)o1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 3/20 0.49
MAPT P10636 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
NPC1 O15118 1/20 0.48
ATM Q13315 1/20 0.48
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
MAOB P27338 2/20 0.47
PTPN11 Q06124 1/20 0.46
MEN1 O00255 1/20 0.46
HSP90AA1 P07900 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 2/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TARBP2 Q15633 1/20 0.46
PDCD4 Q53EL6 1/20 0.46
DHODH Q02127 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6539225 1.00 PPARD (0.49) PPARDMAPTL3MBTL1NPC1ATM
SCHEMBL6539753 0.89 MEN1 (0.48) PPARDMAPTL3MBTL1NPC1ATM
SCHEMBL6229619 0.88 NR4A2 (0.58) PPARDL3MBTL1NPC1ATMALDH1A1
SCHEMBL6228777 0.88 TARBP2 (0.56) PPARDMAPTL3MBTL1NPC1ALDH1A1
SCHEMBL6207458 0.86 PPARD (0.49) PPARDMAPTL3MBTL1NPC1ATM
SCHEMBL6539638 0.85 PPARD (0.47) PPARDMAPTL3MBTL1NPC1ATM
SCHEMBL6539618 0.84 PPARD (0.48) PPARDMAPTL3MBTL1NPC1ATM
SCHEMBL6539723 0.83 PPARD (0.47) PPARDMAPTL3MBTL1NPC1ATM
SCHEMBL6539399 0.83 PPARD (0.47) PPARDL3MBTL1NPC1ATMALDH1A1
SCHEMBL6539519 0.83 PPARD (0.47) PPARDL3MBTL1NPC1ATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 PPARD 1747/4885MAPT 4796/4885L3MBTL1 4432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.